New database aims to unlock secrets of metabolic radiotherapy

NCT ID NCT04104529

Recruiting now Knowledge-focused Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a large database of medical information and blood samples from 350 adults receiving metabolic radiotherapy for thyroid, prostate, or neuroendocrine cancers. The goal is to provide researchers with valuable data to better understand these treatments. No new therapies are being tested; instead, the focus is on collecting information for future studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuroendocrine neoplasm prostate cancer thyroid cancer Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROENDOCRINE TUMORS PROSTATE CANCER THYROID CANCER

Contacts and locations

Locations

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
RECRUITING

Montpellier, 34298, France
Hopital Haut Lévêque
RECRUITING

Bordeaux, Aquitaine, France
Hôpital LaTimone
NOT_YET_RECRUITING

Marseille, Bouches Du Rhône, France
Institut Universitaire du Cancer de Toulouse
RECRUITING

Toulouse, 31100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.